Sarcopenia is rapidly gaining significance as a public health concern within today's ageing population. It is currently defined as an age-related loss of muscle mass, combined with loss of strength, functionality, or both (1) . The associated co-morbidities, in particular, the adverse coexistence of sarcopenia and metabolic syndrome highlight the need to identify effective screening tools and prevention strategies (2) . Since skeletal muscle and adipose tissue have opposing effects on glucose metabolism, the ratio of skeletal muscle to fat may be of particular significance for health outcomes. However, this muscle-fat balance is not currently incorporated into the working definition of sarcopenia. This study therefore sought to identify the influence of body composition within the etiology of the condition.
